UNCLAIMED
Central European Institute of Technology
Overview
The Central European Institute of Technology (CEITEC), located in the Czech Republic, operates within the education sector and is dedicated to advancing research and development in various scientific fields. Established in 2011, CEITEC employs between 201 and 500 individuals and has reported revenue of approximately 30 million USD. One of its notable initiatives is the GMP Pilot Plant, part of the BioPharmaHub, which focuses on the research and development of innovative and generic drugs. This facility is designed for small-batch manufacturing of drug formulations under Good Manufacturing Practice (GMP) standards, enabling the production of clinical batches and the evaluation of drug quality. The GMP Pilot Plant features dedicated areas for producing solid, semi-solid, and liquid dosage forms, along with quality control laboratories for pharmacopoeial testing and stability assessments. CEITEC collaborates with various partners on projects related to pharmacy, cosmetics, and medical devices, showcasing its commitment to supporting research and innovation in drug development and related fields.